Creative Medical Technology Holdings developed a cell-based immunotherapy for Type 1 Diabetes.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Creative Medical Technology Holdings developed a cell-based immunotherapy for Type 1 Diabetes.
How it developed
Newest first. Tap a step to see who reported it.- Creative Medical Technology Holdings received a Notice of Allowance for its ImmCelz™ patent.Sub-event
The company developed a cell-based immunotherapy targeting Type 1 Diabetes.1 source
Coverage
Newest first; wire copies grouped- GlobeNewswireCreative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creati